G. Di Lorenzo et al., Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis, INT A AL IM, 125(2), 2001, pp. 164-175
Background: Nasal polyposis (NP) often coexists with asthma, rhinitis and s
inusitis. Polyp histology typically shows chronic, eosinophilic inflammatio
n. The inflammatory cell infiltrate generally includes eosinophils, lymphoc
ytes, plasma cells and mast cells. Objective: To gain insight into the natu
ral history of NP, we analysed mediator levels and leukocyte values in nasa
l fluids and eosinophil cationic protein (ECP), total IgE levels and eosino
phils in the blood in several groups of both allergic and non-allergic pati
ents with nasal polyps and in patients with allergic rhinitis (AR). Methods
: Thirty-two patients with nasal polyps entered the study. As a control gro
up, we studied 55 patients with AR, i.e. 20 patients with seasonal AR to gr
ass pollen, 24 with AR sensitive to Parietaria and 11 with AR sensitive to
house dust mite (HDM). Eighteen patients with nasal polyps were also allerg
ic patients (8 were sensitive to Parietaria and 10 were sensitive to HDM),
whereas 14 were non-allergic patients. Tryptase and histamine values were a
ssayed in nasal fluids, whereas total IgE was determined in serum. ECP valu
es were assayed both in nasal fluids and serum. Eosinophils were quantified
both in the blood and nasal fluids. Results: Tryptase levels were signific
antly higher in the nasal lavages from patients with NP than in those from
patients without NP (4.7 vs. 3.5 U/I, p < 0.001) and correlated with sympto
m scores (r(s) = 0.42, p < 0.0001). The median levels of histamine in nasal
fluids from patients with NP were also significantly higher than those obs
erved in patients without NP (50.0 vs. 21.3 ng/ml, p < 0.001), but did not
correlate with symptom scores. Finally, the median levels of ECP in nasal f
luids from patients with NP were significantly higher than those observed i
n patients without NP (38.1 vs. 16.1 ng/ml, p < 0.001) and correlated with
symptom scores (r(s) = 0.38, p < 0.001). Analysis of variance showed that,
among the variables studied, the presence of nasal polyps was the factor re
sponsible for the higher levels of tryptase, histamine and ECP in nasal flu
ids. With regard to leukocyte counts in nasal fluids, no significant differ
ences were observed between rhinitis patients with NP and those without NP.
With regard to serum ECP and serum total IgE, no significant differences w
ere detected between the two groups under study. Blood eosinophil levels in
patients with NP were significantly higher than those observed in patients
without NP (5.8 vs. 5.6, p = 0.002). Analysis of variance showed that both
the presence of nasal polyps and the type of sensitisation were important.
Considering the total symptom scores, no significant differences were obse
rved between rhinitis patients with NP and those without NP. Conclusions: T
he present findings are consistent with the view that chronic eosinophil mu
cosal inflammatory disease in NP involves a self-sustaining mechanism, i.e.
local release of inflammatory mediators, independent of allergen stimulati
on of nasal mucosa. Increased release of inflammatory mediators contributes
to the development of nasal polyps, determining oedema and an increased re
cruitment of inflammatory cells. Besides eosinophils, mast cells also play
a key role in this process. Copyright (C) 2001 S. Karger AG, Basel.